MLH1 and cervical carcinoma: We found a statistically significant negative correlation between pGSK-3β(inactivation of GSK-3β) and PMS2 in cervical carcinoma (Table 2) (P = 0.001), while pGSK-3β did not show a statistically significant correlation with MLH1 and MSH2 immunoreactivity (data not shown).